Verrica Pharmaceuticals (VRCA) Return on Equity [ROE] (2018 - 2026)
Verrica Pharmaceuticals (VRCA) posted Return on Equity [ROE] of -308.74% for Q2 2026, down 217.19 percentage points from the prior quarter.
Powered by 
Analysis
Verrica Pharmaceuticals (VRCA) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Verrica Pharmaceuticals' Return on Equity [ROE] came in at -255.30%, up 1237.46 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -168.17 percentage points (FY2020 to FY2025).
- In prior years, Verrica Pharmaceuticals' Return on Equity [ROE] was -1492.76% in FY2024 (-1268.73 pp), -224.03% in FY2023 (-160.73 pp), -63.31% in FY2022 (+43.66 pp) and -106.97% in FY2021 (-19.84 pp).
- Quarterly Return on Equity [ROE] has run from a low of -758.88% in Q1 2024 to a high of -36.57% in Q2 2023 over five years.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2023, with a gain of 159.86 percentage points; the weakest was Q1 2024, with a drop of 718.52 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Verrica Pharmaceuticals | 60.47 Mn | -22.58 Mn | 5.43 Mn | -308.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -308.74% |
| Mar 31, 2026 | -91.55% |
| Dec 31, 2025 | -493.26% |
| Mar 31, 2024 | -759.02% |
| Dec 31, 2023 | -215.88% |
| Sep 30, 2023 | -98.84% |
| Jun 30, 2023 | -38.86% |
| Mar 31, 2023 | -42.99% |
| Dec 31, 2022 | -57.69% |
| Sep 30, 2022 | -92.06% |
| Jun 30, 2022 | -196.74% |
| Mar 31, 2022 | -147.11% |
| Dec 31, 2021 | -95.59% |
| Sep 30, 2021 | -82.84% |
| Jun 30, 2021 | -63.54% |
| Mar 31, 2021 | -71.36% |
| Dec 31, 2020 | -118.37% |
| Sep 30, 2020 | -85.29% |
| Jun 30, 2020 | -62.75% |
| Mar 31, 2020 | -50.22% |
API Access
Verrica Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VRCA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VRCA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VRCA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();